Wound infections after abdominal surgery for gynecological cancer

Celal Akdemir

doi:10.18614/dehm.1813837

Wound infections after abdominal surgery for gynecological cancer

Abstract

BACKGROUND The objective of the present study was to ascertain the incidence of post-laparotomy wound infection and the principal risk factors associated with it. The study focused on a group of patients who had undergone gynaecological cancer surgery. METHODS In this retrospective cohort study, the data of 264 patients who underwent surgical procedures for gynaecological cancer between 15/10/2023 and 15/10/2024 in the Gynaecological Oncology Clinic of Izmir City Hospital were analysed. The demographic, operative, and clinical characteristics of patients with and without wound infection were compared. RESULTS The infection rate of the surgical wound was found to be 11.4% in the patient population who underwent laparotomy for gynaecological malignancy. The risk of wound infection was found to be approximately 14 times higher in patients receiving neoadjuvant chemotherapy (OR = 13.719; p < 0.001) and 6 times higher in patients requiring transfusion (OR = 6.282; p = 0.004). Furthermore, the probability of infection was found to increase with each 1 cm increase in incision length and depth (length OR = 1.196; p = 0.021; depth OR = 1.516; p = 0.005). CONCLUSION The most significant factors associated with the development of wound infection were identified as neoadjuvant chemotherapy and transfusion requirement. The main finding of our study was that incision depth and length were considered as risk factors for wound site infections following abdominal gynaecological malignancy surgeries.

Keywords

References

1. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008 Jun;36(5):309-32. doi:10.1016/j.ajic.2008.03.002.
2. Lachiewicz MP, Moulton LJ, Jaiyeoba O. Pelvic surgical site infections in gynecologic surgery. Infect Dis Obstet Gynecol. 2015;2015:614950. doi:10.1155/2015/614950.
3. Sawyer RG, Evans HL. Surgical site infection—the next frontier in global surgery. Lancet Infect Dis. 2018 May;18(5):477-8. doi:10.1016/S1473-3099(18)30151-4.
4. Emil A, Lital KB, Eithan A, Tamar M, Alia R, Faris N. Surgical site infections after abdominal surgery: incidence and risk factors. A prospective cohort study. Infect Dis (Lond). 2015;47(11):761-7. doi:10.3109/00365548.2015.1055587.
5. Bolac CS, Wallace AH, Broadwater G, Havrilesky LJ, Habib AS. The impact of postoperative nausea and vomiting prophylaxis with dexamethasone on postoperative wound complications in patients undergoing laparotomy for endometrial cancer. Anesth Analg. 2013 May;116(5):1041-7. doi:10.1213/ANE.0b013e3182884389.
6. O’Donnell RL, Angelopoulos G, Beirne JP, Biliatis I, Bolton H, Bradbury M, et al. Impact of surgical site infection (SSI) following gynaecological cancer surgery in the UK: a trainee-led multicentre audit and service evaluation. BMJ Open. 2019 Jan;9(1):e024853. doi:10.1136/bmjopen-2018-024853.
7. Iyer R, Gentry-Maharaj A, Nordin A, Burnell M, Liston R, Manchanda R, et al. Predictors of complications in gynaecological oncological surgery: a prospective multicentre study (UKGOSOC—UK gynaecological oncology surgical outcomes and complications). Br J Cancer. 2014 Feb;112(3):475-84. doi:10.1038/bjc.2013.763.
8. Reiffel AJ, Barie PS, Spector JA. A multi-disciplinary review of the potential association between closed-suction drains and surgical site infection. Surg Infect (Larchmt). 2013 Jun;14(3):244-9. doi:10.1089/sur.2012.058.

9. Kuroki LM, Mullen MM, Massad LS, Wu N, Liu J, Mutch DG, et al. Wound complication rates after staples or suture for midline vertical skin closure in obese women: a randomized controlled trial. Obstet Gynecol. 2017 Jul;130(1):91-9. doi:10.1097/AOG.0000000000002092.
10. MacKeen AD, Schuster M, Berghella V. Suture versus staples for skin closure after cesarean: a meta-analysis. Am J Obstet Gynecol. 2015 May;212(5):621.e1-10. doi:10.1016/j.ajog.2014.12.006.
11. Pevzner L, Swank M, Krepel C, Wing DA, Chan K, Edmiston CE. Effects of maternal obesity on tissue concentrations of prophylactic cefazolin during cesarean delivery. Obstet Gynecol. 2011 Apr;117(4):877-82. doi:10.1097/AOG.0b013e3182117c1d.
12. Hourigan JS. Impact of obesity on surgical site infection in colon and rectal surgery. Clin Colon Rectal Surg. 2011;24(4):283-9. doi:10.1055/s-0031-1295685.
13. Mahdi H, Goodrich S, Lockhart D, DeBernardo R, Moslemi-Kebria M. Predictors of surgical site infection in women undergoing hysterectomy for benign gynecologic disease: a multicenter analysis using the National Surgical Quality Improvement Program data. J Minim Invasive Gynecol. 2014 Sep;21(5):901-9. doi:10.1016/j.jmig.2014.04.012.
14. Lake AG, McPencow AM, Dick-Biascoechea MA, Martin DK, Erekson EA. Surgical site infection after hysterectomy. Am J Obstet Gynecol. 2013 Nov;209(5):490.e1-9. doi:10.1016/j.ajog.2013.06.034.
15. Mahdi H, Gojayev A, Buechel M, Knight J, SanMarco J, Lockhart D, et al. Surgical site infection in women undergoing surgery for gynecologic cancer. Int J Gynecol Cancer. 2014 Apr;24(4):779-86. doi:10.1097/IGC.0000000000000120.
16. Korol E, Johnston K, Waser N, Sifakis F, Jafri HS, Lo M, et al. A systematic review of risk factors associated with surgical site infections among surgical patients. PLoS One. 2013 Dec;8(12):e83743. doi:10.1371/journal.pone.0083743.
17. Subramaniam A, Jauk V, Saade G, Boggess K, Longo S, Clark EAS, et al. The association of cesarean skin incision length and postoperative wound complications. Am J Perinatol. 2022 Apr;39(5):539-45. doi:10.1055/s-0040-1716889.
18. Ioannidis A, Arvanitidis K, Filidou E, Valatas V, Stavrou G, Michalopoulos A, et al. The length of surgical skin incision in postoperative inflammatory reaction. JSLS. 2018 Oct;22(4):e2018.00045. doi:10.4293/JSLS.2018.00045.
19. Kumar L, Pramanik R, Kumar S, Bhatla N, Malik S. Neoadjuvant chemotherapy in gynaecological cancers: implications for staging. Best Pract Res Clin Obstet Gynaecol. 2015 Aug;29(6):790-801. doi:10.1016/j.bpobgyn.2015.04.014.
20. Lim H, Bang SH, Kim Y, Cho SH, Shin W, Kim SI, et al. Clinical implications of neoadjuvant chemotherapy in advanced endometrial cancer: a multi-center retrospective cohort study. BMC Cancer. 2022 Dec;22(1):750. doi:10.1186/s12885-022-09965-1.
21. Zhang C, Li J, Wang L, Sun S, Chen C. The effect of neoadjuvant chemotherapy on surgical site wound infection after immediate breast reconstruction in patients with breast cancer: a meta-analysis. Int Wound J. 2024 Jan;21(1):e14337. doi:10.1111/iwj.14337.
22. Doo DW, Guy MS, Behbakht K, Davidson SA, Sheeder J, Guntupalli SR. Association between preoperative chemotherapy and postoperative complications in patients undergoing surgery for ovarian cancer. Ann Surg Oncol. 2016 Mar;23(3):968-74. doi:10.1245/s10434-015-4955-8.
23. Olsen MA, Higham-Kessler J, Yokoe DS, Butler AM, Vostok J, Stevenson KB, et al. Developing a risk stratification model for surgical site infection after abdominal hysterectomy. Infect Control Hosp Epidemiol. 2009 Nov;30(11):1077-83. doi:10.1086/606163.
24. Remy KE, Hall MW, Cholette J, Juffermans NP, Nicol K, Doctor A, et al. Mechanisms of red blood cell transfusion-related immunomodulation. Transfusion. 2018 Mar;58(3):804-15. doi:10.1111/trf.14488.
25. Li G, Rachmale S, Kojicic M, Shahjehan K, Malinchoc M, Kor DJ, et al. Incidence and transfusion risk factors for transfusion-associated circulatory overload among medical intensive care unit patients. Transfusion. 2011 Feb;51(2):338-43. doi:10.1111/j.1537-2995.2010.02816.x.

Details

Primary Language

English

Subjects

Clinical Sciences (Other)

Journal Section

Research Article

Authors

Celal Akdemir
0000-0002-4070-7583
Türkiye

Publication Date

October 30, 2025

Submission Date

January 21, 2025

Acceptance Date

June 13, 2025

Published in Issue

Year 2025 Volume: 39 Number: 4

DOI

https://doi.org/10.18614/dehm.1813837

IZ

https://izlik.org/JA22MB73JW

Cite

RIS / Bibtex

APA

Akdemir, C. (2025). Wound infections after abdominal surgery for gynecological cancer. Developments and Experiments in Health and Medicine, 39(4), 265-278. https://doi.org/10.18614/dehm.1813837

AMA

1.Akdemir C. Wound infections after abdominal surgery for gynecological cancer. Dev Exp Health Med. 2025;39(4):265-278. doi:10.18614/dehm.1813837

Chicago

Akdemir, Celal. 2025. “Wound Infections After Abdominal Surgery for Gynecological Cancer”. Developments and Experiments in Health and Medicine 39 (4): 265-78. https://doi.org/10.18614/dehm.1813837.

EndNote

Akdemir C (October 1, 2025) Wound infections after abdominal surgery for gynecological cancer. Developments and Experiments in Health and Medicine 39 4 265–278.

IEEE

[1]C. Akdemir, “Wound infections after abdominal surgery for gynecological cancer”, Dev Exp Health Med, vol. 39, no. 4, pp. 265–278, Oct. 2025, doi: 10.18614/dehm.1813837.

ISNAD

Akdemir, Celal. “Wound Infections After Abdominal Surgery for Gynecological Cancer”. Developments and Experiments in Health and Medicine 39/4 (October 1, 2025): 265-278. https://doi.org/10.18614/dehm.1813837.

JAMA

1.Akdemir C. Wound infections after abdominal surgery for gynecological cancer. Dev Exp Health Med. 2025;39:265–278.

MLA

Akdemir, Celal. “Wound Infections After Abdominal Surgery for Gynecological Cancer”. Developments and Experiments in Health and Medicine, vol. 39, no. 4, Oct. 2025, pp. 265-78, doi:10.18614/dehm.1813837.

Vancouver

1.Celal Akdemir. Wound infections after abdominal surgery for gynecological cancer. Dev Exp Health Med. 2025 Oct. 1;39(4):265-78. doi:10.18614/dehm.1813837